Quanterix Q2 revenue $31M (+32% YoY), net loss narrows to $6.1M; raises FY revenue guidance to $110-116M

Quanterix Corp

2023-Q2 EPS reported -$0.33 revenue$59,485,000

Revenue $31.0M, +32% YoY, including $1.5M one-time product/license benefit; 9% sequential growth.
GAAP gross margin 61.7% vs 37.1%; non-GAAP gross margin 56.4% vs 29.1%.
Net loss $6.1M vs $24.9M prior year; near break-even cash flow; cash $329.5M.
Launched LucentAD blood test for Alzheimer's; positive Bio-Hermes study correlation with amyloid PET.
FY 2023 revenue outlook raised to $110-116M; cash burn lowered to $30-35M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Quanterix Corp reported second quarter ended June 30, 2023 results: revenue $31.0 million. Guidance raised.

Period: second quarter ended June 30, 2023
Revenue: $31.0 million
Guidance: raised
Result: reported results

Exact text from the filing

today announced financial results for the three months ended June 30, 2023. Second Quarter Financial Highlights ● Total revenue was $31.0 million versus prior year second quarter total revenue of $23.5 million, an increase of 32%. Second quarter revenue also increased 9% sequentially driven by increased Accelerator Lab and consumables revenue. Second quarter revenue includes a one-time benefit of approximately $1.5 million related to product and license agreements. ● GAAP gross margin was 61.7% compared to prior year second quarter GAAP gross margin of 37.1%. Non-GAAP gross margin was 56.4% compared to prior year second quarter non-GAAP gross margin of 29.1%. ● Net loss was $6.1 million compared to prior year second quarter net loss of $24.9 million.

View on SEC.gov

53 earnings releases filed in the last 30 days. Browse all earnings releases →

Quanterix Corp filing history →

Source: SEC EDGAR

accession 0001558370-23-013642

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.